Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCAGN02385 |
Trade Name | |
Synonyms | INCAGN 02385|INCAGN-02385|tuparstobart |
Drug Descriptions |
INCAGN02385 is a antibody that targets LAG-3, potentially resulting in increased T-cell response (AACR Annual Meeting 2018, Abstract 3919). |
DrugClasses | LAG3 Antibody 18 |
CAS Registry Number | NA |
NCIT ID | C157127 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INCAGN02385 | INCAGN02385 | 0 | 1 |
INCAGN02385 + INCAGN02390 | INCAGN02385 INCAGN02390 | 0 | 1 |
INCAGN02385 + INCAGN02390 + Retifanlimab | INCAGN02385 INCAGN02390 Retifanlimab | 0 | 4 |
INCAGN02385 + Retifanlimab | INCAGN02385 Retifanlimab | 0 | 1 |